Home
Conditions
Splenic Marginal Zone Lymphoma

Clinical trial condition

Splenic Marginal Zone Lymphoma

Explore clinical trials studying Splenic Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

99 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Splenic Marginal Zone Lymphoma trial results

Completed

A Phase I/II Study of Intratumoral Injection of SD-101

NCT02254772

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +25 more
Locations: Stanford University Hospitals and Clinics Stanford, California, United States

View Trial Details

Completed

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

NCT02652715

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

NCT00856388

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01529827

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00005799

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
Locations: City of Hope Medical Center Duarte, California, United States

Stanford University Hospitals and Clinics Stanford, California, United States

University of Colorado Denver, Colorado, United States

Baylor University Medical Center Dallas, Texas, United States

View Trial Details

Completed

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01839916

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma

NCT00711828

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

NCT01789255

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +176 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Splenic Marginal Zone Lymphoma

Splenic Marginal Zone Lymphoma trial results

Related conditions